Adult GM2 gangliosidosis: Improvement of ataxia with GABAergic drugs;Gangliosidosis GM2 del adulto: Mejoría de la ataxia con fármacos GABAérgicos

Neurologia

Volumn 17, Issue 3, 2002, Pages 157-161

  Gazulla Abio J ^a   Benavente Aguilar, I ^a  

^a HOSPITAL SAN JORGE   (Spain)

Author keywords

Adult GM2 gangliosidosis; Ataxia; GABAergic drugs

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE A; GABAPENTIN; NEUROTRANSMITTER; TIAGABINE;

ADULT; ARTICLE; ATAXIA; BRAIN ATROPHY; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MECHANISM; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ENZYME SUBSTRATE; GABAERGIC SYSTEM; GM2 GANGLIOSIDOSIS; HUMAN; LEG; MUSCLE WEAKNESS; MYOKYMIA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING;

ACETIC ACIDS; ADULT; AMINES; ATAXIA; BETA-N-ACETYLHEXOSAMINIDASE; CEREBELLUM; CYCLOHEXANECARBOXYLIC ACIDS; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GANGLIOSIDOSES, GM2; HUMANS; MALE; MYOKYMIA; NIPECOTIC ACIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17944394123     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Diagnóstico de las gangliosidosis GM2 y detección de portadores mediante la determinación de los isoenzimas de la N-acetil-β-D-hexosaminidasa sérica por electroforesis en celogel
2. Enfermedad de Sandhoff (Gangliosidosis GM2 tipo II). Presentación de un caso con estudio clínico y bioquímico. Investigación de portadores
3. The juvenile and chronic forms of GM2 gangliosidosis: Clinical and enzymatic heterogeneity
4. Fenotipo infantil tardío y juvenil de la variante B1 de gangliosidosis GM2
5. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a jewish sibship
6. Gangliosidose a GM2 variant B1 a l'adolescence par une atteinte isolée et plurisystématisée du systéme nerveux central et périphérique
7. Early infantile progressive metabolic encephalopathies: Clinical problems and diagnostic considerations
8. A new mutation in the HEXA gene associated with a spinal muscular atrophy phenotype
9. Late-onset Gm2 gangliosidosis: ashkenazi jewish family with an exon 5 mutation (Tyr180→His) in the Hex A α-chain gene
10. Gangliosidose á GM2 juvénile débutant par une amyotrophie spinale progressive
11. Motor neuron disease and adult hexosaminidase A deficiency in two families: Evidence for multisystem degeneration
12. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: Clinical, morphologic, and biochemical studies of nine cases
13. An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuclear ophthalmoplegia
14. Movement disorders associated with chronic Gm2 gangliosidosis
15. Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide
16. Ultraestructura de la enfermedad de Tay-Sachs
17. The gangliosidoses
18. Encefalomielitis progresiva con rigidez. Aspectos clínicos, electrofisiológicos y tratamiento con gabapentina
19. Spinal internuncial neurones in progressive encephalomyelitis with rigidity
20. Stiff-man syndrome and its variants
21. Neurotransmisión en el sistema nervioso central
22. GABA physiology: Modulation by benzodiazepines and hormones
23. Neurotransmitters in the cerebellum
24. Cerebrospinal fluid gamma-aminobutyric acid variations in cerebellar ataxia
25. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset diabetes mellitus, and polyendocrine autoimmunity
26. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase
27. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies
28. Neurological disorders associated with deficiency of glutamate dehydrogenase
29. Anti-gabaergic neuron autoantibodies in a patient with stiff-man and ataxia
30. Neuroaxonal dystrophy in neuronal storage disorders: Evidence for major GABAergic neuron involvement
31. Calcium channels in neurological disease
32. Gabapentin. Antiepileptic mechanism of action
33. Potential antiepileptic drugs. Tiagabine
34. Improvement of stiff-man syndrome with vigabatrin
35. Effect of gamma-vinyl GABA in Friedreich's ataxia
36. A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia
37. Double-blind crossover study of hydroxytryptophan in patients with degenerative cerebellar diseases
38. Use of buspirone for treatment of cerebellar ataxia. An open-label study
39. Amantadine hydrochloride treatment in heredodegenerative ataxias: A double blind study
40. Treatment of hereditary ataxia with the levorotatory form of hydroxytryptophan
41. Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study
42. A treatment for ataxia
43. Bases théoriques et propositions pour une neuropharmacologie de l'ataxie cérébelleuse